ADIM
APTV icon

Alpha DNA Investment Management’s Aptiv APTV Stock Holding History

Alpha DNA Investment Management’s Portfolio APTV Stock Details APTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,124
Closed -$801K – 188
2023
Q3 		$801K Buy
+8,124
New +$840K 0.33% 62

Other funds holding APTV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Alpha DNA Investment Management's APTV Position: Q4 2023 in Review

Alpha DNA Investment Management sold out of Aptiv (APTV) in Q4 2023, closing a stake of 8,124 shares — an estimated $801K sold.

Alpha DNA Investment Management first reported a position in APTV in Q3 2023 and held it in 1 quarter. The position peaked at $801K in Q3 2023. 748 funds tracked by Wall St. Rank hold APTV as of Q4 2023.

  • Alpha DNA Investment Management reported no remaining Aptiv position as of Q4 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 8,124 Aptiv shares in Q4 2023, an estimated $801K.
  • Alpha DNA Investment Management first reported a position in Aptiv in Q3 2023 and held it in 1 quarter.
  • Alpha DNA Investment Management's Aptiv position peaked at $801K in Q3 2023.
  • 748 funds tracked by Wall St. Rank held Aptiv as of Q4 2023.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.